Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE LA VEZERE (BIS) : revenue, balance sheet and financial ratios

PHARMACIE DE LA VEZERE (BIS) is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTIGNAC-LASCAUX (24290), this company of category PME shows in 2025 a net income positive of 391 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE LA VEZERE (BIS) (SIREN 852140029)
Indicator 2025 2024 2023 2022 2021 2020
Revenue N/C N/C N/C N/C N/C N/C
Net income 391 040 € 327 705 € 264 355 € 450 171 € 245 011 € -15 804 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE DE LA VEZERE (BIS) generates positive net income of 391 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

391 040 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 100%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

100.258%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

45.705%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

40.6%

Solvency indicators evolution
PHARMACIE DE LA VEZERE (BIS)

Sector positioning

Debt ratio
100.26 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average -9 pts over 3 years

In 2025, the debt ratio of PHARMACIE DE LA VEZERE (BIS) (100.26) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
45.7% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average +11 pts over 3 years

In 2025, the financial autonomy of PHARMACIE DE LA VEZERE (BIS) (45.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 330.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

330.059

Liquidity indicators evolution
PHARMACIE DE LA VEZERE (BIS)

Sector positioning

Liquidity ratio
330.06 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent

In 2025, the liquidity ratio of PHARMACIE DE LA VEZERE (BIS) (330.06) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHARMACIE DE LA VEZERE (BIS) in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE DE LA VEZERE (BIS) is estimated at 6 211 716 € (range 4 215 300€ - 9 747 039€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
4215k€ 6211k€ 9747k€
6 211 716 € Range: 4 215 300€ - 9 747 039€
NAF 5 année 2025

Valuation method used

Net Income Multiple
391 040 € × 15.9x = 6 211 717 €
Range: 4 215 300€ - 9 747 039€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE LA VEZERE (BIS) with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE LA VEZERE (BIS)

What is the revenue of PHARMACIE DE LA VEZERE (BIS) ?

The revenue of PHARMACIE DE LA VEZERE (BIS) is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DE LA VEZERE (BIS) profitable?

Yes, PHARMACIE DE LA VEZERE (BIS) generated a net profit of 391 k€ in 2025.

Where is the headquarters of PHARMACIE DE LA VEZERE (BIS) ?

The headquarters of PHARMACIE DE LA VEZERE (BIS) is located in MONTIGNAC-LASCAUX (24290), in the department Dordogne.

Where to find the tax return of PHARMACIE DE LA VEZERE (BIS) ?

The tax return of PHARMACIE DE LA VEZERE (BIS) is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE LA VEZERE (BIS) operate?

PHARMACIE DE LA VEZERE (BIS) operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.